The 2nd annual Precision LBx Summit will unite the biopharma, clinical and diagnostic worlds to champion the application of liquid biopsy testing, across biofluids, biomarkers and disease indications, as the needle shifts on the gold standard of personalized healthcare testing.
Join leaders in the liquid biopsy and molecular pathology communities on a journey to develop and stratify patient responders with circulating biomarkers, standardize tests to be more specific, sensitive and reproducible and prove the clinical utility of liquid biopsy testing.
Showcasing case studies across different biomarkers, biofluids and disease conditions, Precision LBx 2018 will build the narrative on how to improve the standardization, clinical validation and commercialization of liquid biopsies to enhance patient stratification, diagnosis and monitoring with circulating biomarkers.
Drug Developers (Pharma & Biotech) - Conference Earlybird (Book by 17/11/17): USD 1399
Drug Developers (Pharma & Biotech) - Conference (Standard rate): USD 1999
Academics & Clinicians - Conference Earlybird (Book by 17/11/17): USD 599
Academics & Clinicians - Conference (Standard rate): USD 999
Speakers: Jean-Francois Martini (Pfizer), Stefan Scherer (Novartis), John Stille (Eli Lilly), Razelle Kurzrock (UCSD) and many more!